Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-β-lactamases

被引:23
作者
Merino, Maria [1 ]
Perez-Llarena, Francisco J. [1 ]
Kerff, Frederic [3 ]
Poza, Margarita [1 ]
Mallo, Susana [1 ]
Rumbo-Feal, Soraya [1 ]
Beceiro, Alejandro [1 ]
Juan, Carlos [2 ]
Oliver, Antonio [2 ]
Bou, German [1 ]
机构
[1] Complejo Hosp Univ A Coruna, Serv Microbiol INIBIC, La Coruna 15006, Spain
[2] Hosp Son Dureta, Microbiol Serv, Unidad Invest, Palma de Mallorca, Spain
[3] Univ Liege, Ctr Ingn Prot, Liege, Belgium
关键词
Pseudomonas aeruginosa; antibiotic resistance; site-directed mutagenesis; PSEUDOMONAS-AERUGINOSA; BIOCHEMICAL-CHARACTERIZATION; CLINICAL ISOLATE; INTEGRON; GENE;
D O I
10.1093/jac/dkq259
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The new metallo-beta-lactamase VIM-13 has been recently characterized. In comparison with the VIM-1 enzyme, VIM-13 showed 19 amino acid differences, 2 of which were located in the active site centre. The main objective of the present study was to assess whether differences between VIM-1 and VIM-13 beta-lactamases in the active site, at His224Leu and Ser228Arg, are necessary and sufficient to explain the microbiological and biochemical differences between the two enzymes. Single mutants VIM-13 (Leu224His) and VIM-13 (Arg228Ser) and double mutant VIM-13 (Leu224His, Arg228Ser) were created by site-directed mutagenesis with the bla(VIM-13) gene as template. VIM-1, VIM-13 and VIM-13 (Leu224His, Arg228Ser) were purified by affinity chromatography, and kinetic parameters for these enzymes were obtained with ceftazidime, cefepime and ampicillin. Ceftazidime and cefepime MICs (mg/L) for Escherichia coli TG1 expressing VIM-1, VIM-13, VIM-13 (Leu224His), VIM-13 (Arg228Ser) and VIM-13 (Leu224His, Arg228Ser) were > 256 and 64, 6 and 4, 8 and 1, > 256 and 8, and > 256 and 48, respectively. VIM-1, VIM-13 and VIM-13 (Leu224His, Arg228Ser) revealed k(cat)/K-m values (M(-1)s(-1)) for ceftazidime of 3.7 E-4, 1.9 E-4 and 10 E-4, respectively, and revealed k(cat)/K-m values for cefepime of 3.5 E-5, 3 E-4 and 1.5 E-5, respectively. Overall, the results showed that the two residues located in the L3 loop are sufficient to confer the substrate specificity of each enzyme, thus highlighting the importance of the L3 loop of the active site in the evolution of VIM-type metallo-beta-lactamases.
引用
收藏
页码:1950 / 1954
页数:5
相关论文
共 23 条
  • [2] Updated Functional Classification of β-Lactamases
    Bush, Karen
    Jacoby, George A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (03) : 969 - 976
  • [3] Crystal structure of the IMP-1 metallo β-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor:: Binding determinants of a potent, broad-spectrum inhibitor
    Concha, NO
    Janson, CA
    Rowling, P
    Pearson, S
    Cheever, CA
    Clarke, BP
    Lewis, C
    Galleni, M
    Frère, JM
    Payne, DJ
    Bateson, JH
    Abdel-Meguid, SS
    [J]. BIOCHEMISTRY, 2000, 39 (15) : 4288 - 4298
  • [4] Metallo-β-lactamases:: Novel weaponry for antibiotic resistance in bacteria
    Crowder, Michael W.
    Spencer, James
    Vila, Alejandro J.
    [J]. ACCOUNTS OF CHEMICAL RESEARCH, 2006, 39 (10) : 721 - 728
  • [5] On functional and structural heterogeneity of VIM-type metallo-β-lactamases
    Docquier, JD
    Lamotte-Brasseur, J
    Galleni, M
    Amicosante, G
    Frère, JM
    Rossolini, GM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (02) : 257 - 266
  • [6] Purification and biochemical characterization of the VIM-1 metallo-β-lactamase
    Franceschini, N
    Caravelli, B
    Docquier, JD
    Galleni, M
    Frère, JM
    Amicosante, G
    Rossolini, GM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) : 3003 - 3007
  • [7] Genetic and enzymatic properties of metallo-β-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae
    Gacar, GG
    Midilli, K
    Kolayli, F
    Ergen, K
    Gundes, S
    Hosoglu, S
    Karadenizli, A
    Vahaboglu, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (10) : 4400 - 4403
  • [8] Standard numbering scheme for class B β-lactamases
    Galleni, M
    Lamotte-Brasseur, J
    Rossolini, GM
    Spencer, J
    Dideberg, O
    Frère, JM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) : 660 - 663
  • [9] The three-dimensional structure of VIM-2, a Zn-β-lactamase from Pseudomonas aeruginosa in its reduced and oxidised form
    Garcia-Saez, I.
    Docquier, J. -D.
    Rossolini, G. M.
    Dideberg, O.
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2008, 375 (03) : 604 - 611
  • [10] SITE-DIRECTED MUTAGENESIS BY OVERLAP EXTENSION USING THE POLYMERASE CHAIN-REACTION
    HO, SN
    HUNT, HD
    HORTON, RM
    PULLEN, JK
    PEASE, LR
    [J]. GENE, 1989, 77 (01) : 51 - 59